Stock Earnings

Question 1

Newron Pharmaceuticals SpA 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Newron Pharmaceuticals SpA 的总资产为 $63，净profit为 $15

Question 2

NWPHF 的关键财务比率是什么？

Accepted Answer

Newron Pharmaceuticals SpA 的流动比率是 1.01，净利 margin 为 29.41，每股销售为 $2.74。

Question 3

Newron Pharmaceuticals SpA 的收入按细分市场或地理位置如何划分？

Accepted Answer

Newron Pharmaceuticals SpA largest revenue segment is Pharmaceutical Drugs, at a revenue of 8,799,296 in the most earnings release.For geography, Italy & United States is the primary market for Newron Pharmaceuticals SpA, at a revenue of 8,799,296.

Question 4

Newron Pharmaceuticals SpA 是否盈利？

Accepted Answer

yes，根据最新的财务报表，Newron Pharmaceuticals SpA 的净profit为 $15

Question 5

Newron Pharmaceuticals SpA 有负债吗？

Accepted Answer

yes，Newron Pharmaceuticals SpA 的负债为 62

Question 6

Newron Pharmaceuticals SpA 的流通股有多少？

Accepted Answer

Newron Pharmaceuticals SpA 的总流通股为 19.95

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	51	51	9	6	5	5
Revenue Growth (YoY)	467%	467%	50%	20%	0%	-28.99%
Cost of Revenue	0	0	0	0	0	0
Gross Profit	50	50	8	5	5	4
Selling, General & Admin	11	11	7	7	7	8
Research & Development	12	12	12	11	10	15
Operating Expenses	24	24	20	18	18	23
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	21	21	-16	-17	-14	-19
Income Tax Expense	5	5	0	0	0	1
Net Income	15	15	-16	-17	-14	-20
Net Income Growth	-194%	-194%	-6%	21%	-30%	0%
Shares Outstanding (Diluted)	18.56	18.56	17.84	17.84	17.84	17.84
Shares Change (YoY)	4%	4%	0%	0%	0%	0%
EPS (Diluted)	0.85	0.85	-0.9	-0.98	-0.83	-1.17
EPS Growth	-194%	-194%	-7%	17%	-28.99%	4%
Free Cash Flow	-17	-17	-10	-11	-11	-15
Free Cash Flow Per Share	-0.91	-0.91	-0.56	-0.61	-0.61	-0.84
Gross Margin	98.03%	98.03%	88.88%	83.33%	100%	80%
Operating Margin	50.98%	50.98%	-122.22%	-216.66%	-240%	-360%
Profit Margin	29.41%	29.41%	-177.77%	-283.33%	-280%	-400%
Free Cash Flow Margin	-33.33%	-33.33%	-111.11%	-183.33%	-220%	-300%
EBITDA	26	26	-11	-13	-12	-18
EBITDA Margin	50.98%	50.98%	-122.22%	-216.66%	-240%	-360%
D&A For EBITDA	0	0	0	0	0	0
EBIT	26	26	-11	-13	-12	-18
EBIT Margin	50.98%	50.98%	-122.22%	-216.66%	-240%	-360%
Effective Tax Rate	23.8%	23.8%	0%	0%	0%	-5.26%

Newron Pharmaceuticals SpA (NWPHF) Price

NWPHF Stock Price Chart

NWPHF Income

Follow-Up Questions